Leadership Transition at the NCCIH
Dr. Wendy Weber officially assumed the role of director at the National Center for Complementary and Integrative Health on August 23, 2026. National Institutes of Health Director Jay Bhattacharya announced the appointment, marking the end of a leadership search that began in late 2025. Weber previously served as the acting deputy director at the center since October 2025. Her new position grants her oversight of a $170 million annual budget aimed at studying the safety and effectiveness of non-traditional medical practices.
Bhattacharya expressed confidence in Weber’s background, citing her experience in pain management research and whole-person health. The NCCIH focuses on the science behind complementary treatments, ranging from nutritional interventions to mindfulness practices. Weber will lead efforts to determine how these approaches fit into broader healthcare systems. Her tenure begins as the agency seeks to refine its focus on chronic disease and evidence-based medicine.
A History of Scientific Development
Weber brings over 15 years of experience within the NIH infrastructure to her new role. She spent a decade leading the NCCIH Clinical Research Branch, where she managed the growth of the unit from its inception. Her work extended beyond the center, as she provided scientific leadership for the NIH-VA-DoD Pain Management Collaboratory. This specific initiative sought advancements in non-addictive pain treatments, including the use of acupuncture and stress reduction techniques.
Before joining the federal government in 2009, Weber conducted clinical trials at Bastyr University in Kenmore and Massachusetts General Hospital in Boston. Her early academic career included investigations into botanical interventions. She notably studied Echinacea for the treatment of the common cold. These roles established her reputation for blending clinical observations with systematic research protocols.
Bridging Clinical Practice and Research
Weber holds a unique academic background that combines clinical training with advanced doctoral research. She earned her naturopathic degree from Bastyr University, followed by a Master of Public Health and a Ph.D. from the University of Washington. She was the first naturopathic physician to receive a career development award from the NIH. Her research during that period focused on the use of St. John's Wort for attention-deficit/hyperactivity disorder.
This academic trajectory positions her as a link between traditional clinical practices and modern epidemiological methods. She serves as a representative for those who argue that complementary health requires rigorous scientific validation to gain mainstream acceptance. Her work at the NIH has consistently focused on clinical trials that prioritize data over anecdote. The agency aims to continue this path under her guidance.
Future Implications for Federal Health Research
Dr. David Shurtleff, who served as acting director since October 2025, stepped down upon Weber’s appointment. His tenure provided stability during a period of administrative transition. The NCCIH remains one of 27 distinct institutes and centers under the NIH banner. These entities operate as the primary federal agency for medical research in the United States, investigating the causes and treatments for a wide spectrum of conditions.
Industry observers will monitor how Weber’s leadership influences future grant distributions. The focus on pain management remains a priority for the government as the nation continues to navigate the complexities of long-term health and wellness. Weber’s appointment signals a continuation of the agency’s commitment to evidence-based science. Stakeholders expect her to maintain the current trajectory of clinical trial expansion while exploring new areas of nutritional intervention.